Hints and tips:
...Idexx said in October that the animal health market had experienced a “V-shaped recovery”....
...In 2015, he advised Mylan on a successful defence against a hostile bid by Teva Pharmaceuticals....
...China's regulator has approved 60,000 TCM medicines — almost a third of the country's pharmaceuticals market, the world's second largest....
...Smart Reads Patent shadow A trio of pharma groups — Teva Pharmaceuticals, Mylan and Akorn — are trying to have Allergan’s intellectual property invalidated so they can launch cheaper copycat versions of...
...In 2012, the group, then called Watson, was a run-of-the-mill producer of generic drugs with a market capitalisation of $8bn — a fraction of the $120bn it is worth today....
...It is more than two years since Watson, now called Actavis, embarked on a multiyear acquisition spree that saw it go from a copycat drugmaker with a market capitalisation of $8bn to a top 10 pharmaceutical...
..., the pharmaceutical company that helped to expand (and protect) the business in the first six months of 2015....
...The proposed deal comes only a year after Swiss-based Actavis was acquired for €4.5bn by Watson of the US – and lent its name to the combined group....
...It was forced to come up with a novel approach in the US courts to block US generic drugmaker Mylan....
...If Watson is successful, the deal would help the company compete in a consolidating generic drugs market against rivals including Teva, Novartis and Mylan....
...The other company that will be allowed to launch the generic version Thursday is Pfizer’s generic partner, Watson Pharmaceuticals, which has FDA-approval to market the drug in the US and could easily take...
...The market’s disappointment over the results weighed on the healthcare sector with Watson Pharmaceuticals falling 1.2 per cent to $62.63 and Mylan losing 2.5 per cent to $24.23....
...But buying Ratiopharm would catapult it into the generic big leagues, on a par with companies such as Mylan and Watson that each control about 6 per cent of global sales, according to BCC....
International Edition